Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-C796234-100 | 100 µl (1 mg/ml) | $434 |
1 of 2
2 of 2
Monoclonal Mouse anti‑Human SH3BGR Antibody (clone OTI1G8, IHC, WB) LS‑C796234
Monoclonal Mouse anti‑Human SH3BGR Antibody (clone OTI1G8, IHC, WB) LS‑C796234
Antibody:
SH3BGR Mouse anti-Human Monoclonal (OTI1G8) Antibody
Application:
IHC, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Antibody:
SH3BGR Mouse anti-Human Monoclonal (OTI1G8) Antibody
Application:
IHC, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Specifications
Description
SH3BGR antibody LS-C796234 is an unconjugated mouse monoclonal antibody to human SH3BGR. Validated for IHC and WB.
Target
Human SH3BGR
Synonyms
SH3BGR | 21-GARP | 21-glutamic acid-rich protein | SH3GBR | SH3BGR protein
Host
Mouse
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Clone
OTI1G8
Conjugations
Unconjugated
Purification
Affinity chromatography
Modifications
Unmodified
Immunogen
Full length human recombinant protein of human SH3BGR (NP_031367) produced in E.coli.
Applications
- IHC (1:500)
- Western blot (1:2000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About SH3BGR
Publications (0)
Customer Reviews (0)
Featured Products
![SH3BGR Antibody - Immunoperoxidase of monoclonal antibody to SH3BGR on formalin-fixed paraffin-embedded human skeletal muscle. [antibody concentration 3 ug/ml]](https://lsbio-7d62.kxcdn.com//image2/sh3bgr-antibody-clone-3b7-ls-c133435/51639_1258657.jpg)
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Reactivity:
Bovine
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024
Date Requested: 4/27/2024
